Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

GMP Feasibility Study

  • First published: 23 October 2020
  • Last modified: 23 October 2020
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
ocds-kuma6s-105067
Published by:
Cardiff University
Authority ID:
AA0258
Publication date:
23 October 2020
Deadline date:
18 November 2020
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

The School of Pharmacy, Cardiff University, wishes to appoint a contractor to undertake a specialist evaluation and feasibility study of Cardiff University Redwood Building currently unlicenced Good Manufacturing Practice (GMP) suite for adaptation and recommissioning for alternative use. The successful Bidder will be required to conduct a feasibility study for change of use of an existing cleanroom for manufacture of GMP-compliant advanced therapies (cell and gene therapies). The existing cleanroom was built in 2010 according to MHRA specifications to enable small scale development of pharmaceutics, process optimization and product development. The unit is split into two areas, each with their own designated change facility: a pharmaceutical grade area and a grade B sterile production area. The 106m2 EU GMP Class B/ISO 14644-1 Class 5 floor space currently contains four double glove, rigid positive pressure Class A Isolators, a horizontal Laminar Air Flow Cabinet, and a negative pressure 4 glove hazardous products isolator. The unit also provides 45m2 of unclassified production space, with an adjoining preparation room, a microbiology facility with Class II safety cabinet and non-pharmaceutical autoclaves. Intended use: The facility is intended to be modified as a translational GMP Facility that will function as a versatile platform for developing clinically applicable cell and gene therapies for cancer, neurodegenerative and other diseases and for regenerative medicine products.

Full notice text

CONTRACT NOTICE – NATIONAL

SERVICES

1 Authority Details

1.1

Authority Name and Address


Cardiff University

Procurement Services, McKenzie House, 30-36 Newport Road,

Cardiff

CF24 0DE

UK

Julie Paynter, Senior Procurement Officer

+44 2920879648


http://www.cardiff.ac.uk/business/why-work-with-us/for-suppliers
https://in-tendhost.co.uk/cardiffuniversity/aspx/Home
https://in-tendhost.co.uk/cardiffuniversity/aspx/Home

1.2

Address from which documentation may be obtained

As in 1.1

1.3

Completed documents must be returned to:

As in 1.1

2 Contract Details

2.1

Title

GMP Feasibility Study

2.2

Description of the goods or services required

The School of Pharmacy, Cardiff University, wishes to appoint a contractor to undertake a specialist evaluation and feasibility study of Cardiff University Redwood Building currently unlicenced Good Manufacturing Practice (GMP) suite for adaptation and recommissioning for alternative use.

The successful Bidder will be required to conduct a feasibility study for change of use of an existing cleanroom for manufacture of GMP-compliant advanced therapies (cell and gene therapies).

The existing cleanroom was built in 2010 according to MHRA specifications to enable small scale development of pharmaceutics, process optimization and product development. The unit is split into two areas, each with their own designated change facility: a pharmaceutical grade area and a grade B sterile production area. The 106m2 EU GMP Class B/ISO 14644-1 Class 5 floor space currently contains four double glove, rigid positive pressure Class A Isolators, a horizontal Laminar Air Flow Cabinet, and a negative pressure 4 glove hazardous products isolator. The unit also provides 45m2 of unclassified production space, with an adjoining preparation room, a microbiology facility with Class II safety cabinet and non-pharmaceutical autoclaves.

Intended use:

The facility is intended to be modified as a translational GMP Facility that will function as a versatile platform for developing clinically applicable cell and gene therapies for cancer, neurodegenerative and other diseases and for regenerative medicine products.

NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=105067.

2.3

Notice Coding and Classification

79314000 Feasibility study
1022 Cardiff and Vale of Glamorgan

2.4

Total quantity or scope of tender

The School of Pharmacy, Cardiff University, wishes to appoint a contractor to undertake a specialist evaluation and feasibility study of Cardiff University Redwood Building currently unlicenced Good Manufacturing Practice (GMP) suite for adaptation and recommissioning for alternative use.

The successful Bidder will be required to conduct a feasibility study for change of use of an existing cleanroom for manufacture of GMP-compliant advanced therapies (cell and gene therapies).

The existing cleanroom was built in 2010 according to MHRA specifications to enable small scale development of pharmaceutics, process optimization and product development. The unit is split into two areas, each with their own designated change facility: a pharmaceutical grade area and a grade B sterile production area. The 106m2 EU GMP Class B/ISO 14644-1 Class 5 floor space currently contains four double glove, rigid positive pressure Class A Isolators, a horizontal Laminar Air Flow Cabinet, and a negative pressure 4 glove hazardous products isolator. The unit also provides 45m2 of unclassified production space, with an adjoining preparation room, a microbiology facility with Class II safety cabinet and non-pharmaceutical autoclaves.

Intended use:

The facility is intended to be modified as a translational GMP Facility that will function as a versatile platform for developing clinically applicable cell and gene therapies for cancer, neurodegenerative and other diseases and for regenerative medicine products.

3 Conditions for Participation

3.1

Minimum standards and qualification required

As stated in the Invitation to Tender (ITT) documents.

4 Administrative Information

4.1

Type of Procedure

Single stage

4.2

Reference number attributed to the notice by the contracting authority

CU.473.JP

4.3

Time Limits

Time-limit for receipt of completed tenders
    18-11-2020  Time  12:00

Estimated award date
 04-12-2020

4.5

Language or languages in which tenders or requests to participate can be drawn up

EN 

Welsh

4.6

Tender Submission Postbox

5 Other Information

5.1

Additional Information

All tender costs and liabilities incurred by bidders shall be the sole responsibility of bidders.

The University reserves the right to award the contract in whole or in part.

The University reserves the right to annul the tendering process and not award any contract.

All documents to be priced in GBP and all payments made in GBP.

All documents to be priced in GBP excluding VAT.

(WA Ref:105067)

5.2

Additional Documentation

5.3

Publication date of this notice

 23-10-2020

Coding

Commodity categories

ID Title Parent category
79314000 Feasibility study Market research services

Delivery locations

ID Description
1022 Cardiff and Vale of Glamorgan

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

Document family

Notice details
Publication date:
23 October 2020
Deadline date:
18 November 2020 00:00
Notice type:
Contract Notice
Authority name:
Cardiff University
Publication date:
03 December 2020
Notice type:
Contract Award Notice
Authority name:
Cardiff University

About the buyer

Main contact:
N/a
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.